AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 14,026
-74 (-0.52%)
Nov 26, 2025, 1:49 PM BST
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 218.65 billion as of November 26, 2025. Its market cap has increased by 37.04% in one year.
Market Cap
218.65B
Enterprise Value
236.92B
Revenue
43.24B
Ranking
n/a
PE Ratio
31.49
Stock Price
14,026.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 218.65B, an increase of 4,705.08%. That is a compound annual growth rate of 12.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 218.65B | 34.73% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | 96.14B | -3.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 72.08B |
| Haleon | 33.11B |
| Smith & Nephew | 10.65B |
| ConvaTec Group | 4.62B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.62B |
| Oxford Nanopore Technologies | 1.32B |